Hepatopulmonary syndrome

Cardiovascular Diseases and Liver Transplantation

Volumn , Issue , 2011, Pages 179-192

  Fauconnet, Pascal ^a   Ho, Vincent ^b,c   Pastor, Catherine ^a   Schiffer, Eduardo ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^c TOWNSVILLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864303145     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3390/ma3042684     Document Type: Chapter

References (47)

1. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB: Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD). J Hepatol 2005;42:924-7.
2. Swanson KL, Wiesner RH, Krowka MJ: Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology 2005;41:1122-9.
3. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB: Pulmonary-hepatic vascular disorders (PHD). Eur Resp. J 2004; 24(5):861-80.
4. Gomez FP, Martinez-Palli G, Barbera JA, Roca J, Navasa M, Rodriguez-Roisin R: Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology 2004;40:660-6.
5. Gaines DI, Fallon MB: Hepatopulmonary syndrome. Liver Int 2004; 24: 397-401.
6. Schiffer E, Majno P, Mentha G, Giostra E, Burri H, Klopfenstein CE, Beaussier M, Morel P, Hadengue A, Pastor CM: Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: a prospective study in 90 patients. Am J Transpl 2006;6:1430-7.
7. Martinez GP, Barbera JA, Visa J, Rimola A, Pare JC, Roca J, Navasa M, Rodes J, Rodriguez-Roisin R: Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001;34:651-7.
8. Lima BL, Franca AV, Pazin-Filho A, Araujo WM, Martinez JA, Maciel BC, Simoes MV, Terra-Filho J, Martinelli AL: Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc 2004;79:42-8.
9. Luo B, Abrams GA, Fallon MB: Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol 1998;29: 571-8.
10. Kim BJ, Lee SC, Park SW, Choi MS, Koh KC, Paik SW, Lee SH, Hong KP, Park JE, Seo JD: Characteristics and prevalence of intrapulmonary shunt detected by contrast echocardiography with harmonic imaging in liver transplant candidates. Am J Cardiol 2004;94:525-8.
11. Lenci I, Alvior A, Manzia TM, Toti L, Neuberger J, Steeds R: Saline contrast echocardiography in patients with hepatopulmonary syndrome awaiting liver transplantation. J Am Soc Echocardiogr 2009; 22: 89-94.
12. Poterucha JJ, Krowka MJ, Dickson ER, Cortese DA, Stanson AW, Krom RA: Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology 1995; 21: 96-100
13. Arguedas MR, Singh H, Faulk DK, Fallon MB: Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin Gastroenterol Hepatol 2007; 5: 749-54
14. Cremona G, Higenbottam TW, Mayoral V, Alexander G, Demoncheaux E, Borland C, Roe P, Jones GJ: Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995; 8: 1883-5.
15. Rolla G: Hepatopulmonary syndrome: role of nitric oxide and clinical aspects. Dig Liver Dis 2004; 36: 303-8.
16. Rolla G, Brussino L, Colagrande P, Scappaticci E, Morello M, Bergerone S, Ottobrelli A, Cerutti E, Polizzi S, Bucca C: Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med 1998; 129: 375-8.
17. Battaglia SE, Pretto JJ, Irving LB, Jones RM, Angus PW: Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation. Hepatology 1997; 25: 1228-32.
18. Chang SW, Ohara N: Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model of the hepatopulmonary syndrome. Am Rev Respir Dis 1992; 145: 798-805
19. Fallon MB, Abrams GA, McGrath JW, Hou Z, Luo B: Common bile duct ligation in the rat: a model of intrapulmonary vasodilation and hepatopulmonary syndrome. Am J. Physiol 1997; 272:G779-84.
20. Schraufnagel DE, Malik R, Goel V, Ohara N, Chang SW: Lung capillary change in hepatic cirrhosis in rats. Am J Physiol 1997; 272:L139-47.
21. Nunes H, Lebrec D, Mazmanian M, Capron F, Heller J, Tazi KA, Zerbib E, Dulmet E, Moreau R, Dinh-Xuan A, Simmoneau G, Hervé P: Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am. J. Respir. Crit Care Med 2001;164:879-885.
22. Fallon MB, Abrams GA, Luo B, Hou Z, Dai J, Ku DD: The role of endothelial nitric oxide in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997; 13: 606-14.
23. Luo B, Tang L, Wang Z, Zhang J, Ling Y, Feng W, Sun JZ, Stockard CR, Frost AR, Chen YF, Grizzle WE, Fallon MB: Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. Gastroenterology 2005;129: 682-95
24. Ling Y, Zhang J, Luo B, Song D, Liu L, Tang L, Stockard CR, Grizzle WE, Ku DD, Fallon MB: The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology 2004;39:1593-602.
25. Luo B, Liu L, Tang L, Zhang J, Stockard CR, Grizzle WE, Fallon MB: Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 2003;38:556-63.
26. Rabiller A, Nunes N, Lebrec D, Tazi KA, Wartski M, Dulmet E, Libert JM, Mougeot C, Moreau R, Mazmanian M, Humbert M, Hervé P: Prevention of Gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Resp Crit Care Med 2002;166:514-517
27. Sztrymf B, Rabiller A, Nunes H, Savale L, Lebrec D, Le Pape A, de Montpreville V, Mazmanian M, Humbert M, Hervé P: Prevention of hepatopumonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Resp J 2004; 23: 752-8.
28. Imamura M, Luo B, Limbird JN, Vitello AM, Oka M, Ivy DD, McMurtry IF, Garat CV, Fallon MB, Carter EP: Hypoxic Pulmonary Hypertension is Prevented in Rats with Common Bile Duct Ligation. J Appl Physiol 2004; 29:29
29. Rodriquez-Roisin R, Krowka MJ, Herve P, Fallon MB: Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD). J Hepatol 2005; 42: 924-7
30. Gupta LB, Kumar A, Jaiswal AK, Yusuf J, Mehta V, Tyagi S, Tempe DK, Sharma BC, Sarin SK: Pentoxifylline therapy for hepatopulmonary syndrome: a pilot study. Arch Intern Med 2008;168:1820-3.
31. Krug S, Seyfarth HJ, Hagendorff A, Wirtz H: Inhaled iloprost for hepatopulmonary syndrome: improvement of hypoxemia. Eur J Gastroenterol Hepatol 2007; 19:1140-3.
32. Rolla G, Bucca C, Brussino L: Methylene blue in the hepatopulmonary syndrome. N Engl J Med 1994; 331:1098
33. Brussino L, Bucca C, Morello M, Scappaticci E, Mauro M, Rolla G: Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome. Lancet 2003; 362: 43-4
34. Vercelino R, Tieppo J, Dias AS, Marroni CA, Garcia E, Meurer L, Picada JN, Marroni NP: N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. Basic Clin Pharmacol Toxicol 2008;102:370-6'
35. Abrams GA, Sanders MK, Fallon MB: Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl 2002; 8: 391-396
36. Arguedas MR, Drake BB, Kapoor A, Fallon MB: Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome. Gastroenterology 2005;128: 328-33.
37. Krowka MJ: Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin. Chest Med. 2005; 26: 587-597
38. Palma DT, Fallon MB: The hepatopulmonary syndrome. J Hepatol 2006; 45: 617-25.
39. UNOS:www.unos.org/policiesandbylaws/policies.asp?ressources=true.Organ distribution: allocation of livers
40. Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C: Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003;125:1042-52.
41. Mohamed R, Freeman JW, Guest PJ, Davies MK, Neuberger JM: Pulmonary gas exchange abnormalities in liver transplant candidates. Liver Transpl 2002;8:802-8
42. Taille C, Cadranel J, Bellocq A, Thabut G, Soubrane O, Durand F, Ichai P, Duvoux C, Belghiti J, Calmus Y, Mal H: Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation 2003;75:1482-9.
43. Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, Pardo M, Marotta P, Uemoto S, Stoffel MP, Benson JT: Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004;10:174-182
44. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB: Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003;37:192-7.
45. Gupta S, Castel H, Rao RV, Picard M, Lilly L, Faughnan ME, Pomier-Layrargues G: Improved Survival After Liver Transplantation in Patients with Hepatopulmonary Syndrome. Am J Transplant 2010;10(2):354-63.
46. Collisson EA, Nourmand H, Fraiman MH, Cooper CB, Bellamy PE, Farmer DG, Vierling JM, Ghobrial RM, Busuttil RW: Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl 2002;8: 925-31.
47. Yi HM, Wang GS, Yi SH, Yang Y, Cai CJ, Chen GH: Prospective evaluation of postoperative outcome after liver transplantation in hepatopulmonary syndrome patients. Chin Med J 2009;122: 2598-602.